A detailed history of Chevy Chase Trust Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 23,049 shares of UTHR stock, worth $8.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,049
Previous 11,159 106.55%
Holding current value
$8.9 Million
Previous $3.55 Million 132.39%
% of portfolio
0.03%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $3.7 Million - $4.32 Million
11,890 Added 106.55%
23,049 $8.26 Million
Q2 2024

Jul 22, 2024

BUY
$228.26 - $319.04 $2.55 Million - $3.56 Million
11,159 New
11,159 $3.55 Million
Q1 2020

May 13, 2020

SELL
$79.39 - $115.35 $28,342 - $41,179
-357 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$78.31 - $95.34 $27,956 - $34,036
357 New
357 $31,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.